Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Should we redefine hypertension?

Thomas D Giles1

  • 1Department of Medicine, Tulane University School of Medicine, 109 Holly Drive, Metairie, LA 70005, USA. tgiles4@cox.net

Current Cardiology Reports
|October 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood pressure is a beautiful (but imperfect) biomarker of hypertension. The quixotic quest that fuels the hypertension guideline industry.

Journal of clinical hypertension (Greenwich, Conn.)·2018
Same author

Prehypertension-What Is It and Should It Be Treated?

Journal of clinical hypertension (Greenwich, Conn.)·2017
Same author

Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide.

American journal of physiology. Heart and circulatory physiology·2017
Same author

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.

Journal of hypertension·2017
Same author

Apolipoproteins and Blood Pressure: A Story of Evolution in Biomarker Analysis.

Journal of the American College of Cardiology·2017
Same author

Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2017

Hypertension is a complex condition, not defined by a single blood pressure threshold. Evaluating blood pressure alongside other risk factors helps reduce risks of heart attack, stroke, and kidney disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Neurology

Background:

  • Traditional hypertension definitions rely on fixed blood pressure thresholds.
  • Recent evidence suggests no clear threshold separates high-risk from low-risk individuals.
  • Cardiovascular risk is multifactorial, not solely determined by blood pressure levels.

Purpose of the Study:

  • To redefine hypertension based on individual risk assessment.
  • To emphasize the importance of evaluating blood pressure in the context of other cardiovascular risk factors.
  • To guide physicians in reducing overall patient risk for major adverse cardiovascular events.

Main Methods:

  • Review of current hypertension diagnostic criteria.
  • Analysis of epidemiological data on cardiovascular risk factors.

Related Experiment Videos

  • Integration of blood pressure measurements with other risk indicators.

    • Main Results:

    • Demonstrated that a single blood pressure threshold is insufficient for risk stratification.
    • Highlighted the complex interplay between blood pressure and other cardiovascular risk factors.
    • Proposed a more individualized approach to hypertension management.

    Conclusions:

    • Hypertension is best understood as blood pressure exceeding an individual's optimal level.
    • Comprehensive risk assessment is crucial for effective hypertension management.
    • This approach aims to reduce the global risk of myocardial infarction, stroke, and chronic kidney disease.